For the Inventor, By the Inventor

Enter assignee name

Research Triangle Park, NC, United States of America

Glaxo Inc.

USPTO Granted Patents = 81

Forward Citations = 2,004

Loading Chart...

Loading Chart...

107 inventors (with patents filed for the assignee):

Giovanni Gaviraghi (17 out of 22 patents)

Claudio Semeraro (9 out of 19 patents)

Dino Micheli (9 out of 9 patents)

4. Daniele Pieraccioli (9 out of 9 patents)

5. Alcide Perboni (7 out of 11 patents)

6. Alan D Borthwick (7 out of 31 patents)

7. Stephen V Frye (6 out of 15 patents)

8. Terrence P Kenakin (6 out of 6 patents)

9. Joel E Shaffer (6 out of 6 patents)

10. Paul L Feldman (6 out of 9 patents)

11. Marcus F Brackeen (6 out of 6 patents)

12. Thomas N Wheeler (6 out of 33 patents)

13. John Joseph Partridge (5 out of 46 patents)

14. Giorgio Tarzia (5 out of 5 patents)

15. Tino Rossi (4 out of 7 patents)

Core Competencies:

Benzodiazepines

Inhalation Devices

Analgesic Formulations

Dihydropyridine

Indole Derivatives

Cyclic Antitumor Compounds

Heterocyclic Compounds

Aerosol Drug Formulations

Cardiovascular Agents

Carbamate Derivatives

Cyclopentene Derivatives

Safety Closures

81 patents: Sort by Forward Citations

1. 5641775 - 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or antagonists (1997-06-24),

2. 5637697 - 1,5-benzodiazepine derivatives and their use in medicine (1997-06-10),

3. 5587374 - 10(1-hydroxyethyl)-11-oxo-1-azatricyclo/7.2.0.0..sup.3.8/ (1996-12-24),

4. 5580895 - 1,5-benzodiazepine derivatives (1996-12-03),

5. 5576312 - 1-azatricyclo[7.2.0.0.sup.3,8 ]undec-2-ene-2-carboxylates as (1996-11-19),

6. 5510367 - Indole derivatives (1996-04-23),

7. 5486514 - Carbamate derivatives (1996-01-23),

8. 5457098 - 17 .beta.acyl 6 azaandrost-4,6 diazo-4-ene-3-ones (1995-10-10),

9. 5455257 - Lacidipine for the treatment of arteriosclerosis (1995-10-03),

10. 5442892 - System for facilitate recycling goods from defective packages on a (1995-08-22),

11. 5426196 - Synthesis of diaryl methanes (1995-06-20),

12. 5426104 - Tricyclic carbapenem compounds, methods of preparation and methods of use (1995-06-20),

13. 5421492 - Metered aerosol dispensing apparatus and method of use thereof (1995-06-06),

14. 5415162 - Multi-dose dry powder inhalation device (1995-05-16),

15. 5407931 - Derivatives of 1-azatricyclo[7.2.03,8]undec-2-ene-2-carboxyclic acid (1995-04-18),

Company Overview

Glaxo Inc., headquartered in Research Triangle Park, NC, specializes in the development and manufacturing of pharmaceutical compounds. The company focuses on a diverse range of core technology topics, including benzodiazepines, inhalation devices, and analgesic formulations. With expertise in dihydropyridine and indole derivatives, Glaxo Inc. also explores cyclic antitumor and heterocyclic compounds, alongside innovative aerosol drug formulations. This positions the company as a key player in advancing therapeutic solutions within the pharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

81 Patents

#10 in Research Triangle Park, NC

#118 in North Carolina

#4,579 in US

#9,354 in the World

Research Triangle Park, NC, United States of America

Glaxo Inc.

Forward Citations = 2,004

107 inventors:

Giovanni Gaviraghi (17 out of 22 patents)

Claudio Semeraro (9 out of 19 patents)

Dino Micheli (9 out of 9 patents)

4. Daniele Pieraccioli (9 out of 9 patents)

5. Alcide Perboni (7 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glaxo Inc.. Retrieved from https://idiyas.com/company/glaxo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…